• Skip to primary navigation
  • Skip to main content

New York Society of Addiction MedicineNew York Society of Addiction Medicine Logo

  • NYSAM on Twitter
  • NYSAM on Facebook
  • NYSAM on LinkedIn
  • Join Mailing List
  • Past Conferences
  • 2023 Annual Conference
  • About Addiction Medicine
  • Key Issues
    • Advocacy
    • Opioids
    • Marijuana
    • Access to Care
    • More Issues
  • About
    • About NYSAM
    • Leadership
    • Contact NYSAM
    • News
    • Annual Conference
  • Resources
    • For Patients
    • For Physicians
    • Webinars
    • Articles
    • Employment
  • Membership
    • NYSAM Committees
    • Become a NYSAM Member
    • Renew Membership
    • Our Members
  • Annual Conference
  • Past Conferences
  • Donate
  • Sign Up for Our Newsletter

Advocacy

NYSAM uses its voice and membership to promote public policies that advance addiction medicine and promote access to treatment.

June 16, 2016 by NYSAM

Public Policy Statement: Update from the American Academy of Pediatrics on the Impact of Marijuana Legalization

The AAP has issued a policy statement entitled, “The Impact of Marijuana Policies on Youth: Clinical, Research, and Legal Update.”…

January 14, 2016 by NYSAM

Public Policy Statement: ASAM Statement on Marijuana, Cannabinoids and Legalization

Adoption Date: September 21, 2015 Below is an excerpt from the policy statement. To read the entire document, please view…

September 21, 2015 by NYSAM

Public Policy Action: Marijuana, Cannabinoids and Legalization

In recent years, many states have considered or enacted policies to legalize cannabis use. As of this writing, Alaska, Colorado, Oregon,…

June 4, 2014 by NYSAM

Public Policy Statement: New York Society of Addiction Medicine Opposes Passage of Senate Bill 4406-B

The New York Society of Addiction Medicine opposes passage of Senate Bill 4406-B for the following reasons: There is insufficient…

June 4, 2014 by NYSAM

Public Policy Statement: Senate’s Joint Task Force on Heroin and Opioid Addiction Releases Report and Legislative Recommendations

The New York State Senate Joint Task Force on Heroin and Opioid Addiction today released a report summarizing the findings of statewide forums held to examine the issues surrounding the increase in drug abuse, addiction and drug related crimes in New York. The report includes a comprehensive package of bills recommended for action this legislative session that target prevention, treatment, and enforcement issues raised during extensive testimony provided by dozens of experts, parents, and concerned New Yorkers.

March 28, 2012 by NYSAM

Public Policy Statement: NYSAM Board Votes to Support MSSNY’s Position Paper on Prescription Drug Abuse and NYSAM Public Policy Forum is a Success with over 100 in attendance.

At NYSAM’s meeting on March 19, 2012,  the board voted to endorse MSSNY’s position paper on prescription drug abuse. The…

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to page 5
  • Go to Next Page »

View by Topic

  • All Topics
  • Access to Care
  • Advocacy
  • Alcohol
  • Benzodiazepines
  • Evidence-based Research
  • Harm reduction
  • Marijuana
  • Opioids
  • Stimulants

Connect with Us

  • NYSAM on Twitter
  • NYSAM on Facebook
  • NYSAM on LinkedIn

Join our mailing list to stay updated on upcoming events and chapter news.

  • This field is for validation purposes and should be left unchanged.

NYSAM is a State Chapter of the American Society of Addiction Medicine (ASAM)

  • Become a Member
  • About Addiction Medicine
  • Addiction Resources
  • Physician Resources
  • Key Issues
NYSAM logo in footer

865 Merrick Avenue
Westbury, NY 11590

For inquiries, contact Philip Schuh, CPA,MS, Executive Vice President MSSNY
516-488-6100, ext.397
nysocietyofaddictionmedicine@gmail.com

© 2023 New York Society of Addiction Medicine. Website by Status Forward.

Join the Conversation

Stay Informed. Share your views.

For the latest news and evidence on substance use disorders and addiction, follow NYSAM on Twitter.

Follow Us

×

2023 conference announcement

×